April 15, 2015. MOUNTAIN VIEW, Calif. NASA Ames Research Center

Scanadu Inc., the Silicon Valley-based medtech company, today announced that Qualcomm Tricorder XPRIZE finalist teams Scanadu, led by Walter de Brouwer, CEO of Scanadu, and zensor, led by Jim McLaughlin, CTO of Intelesens and Director at NIBEC - University of Ulster, have joined forces to create Team Scanadu/Intelesens. The move brings together complementary expertise from both teams in their continued quest for the $10M Qualcomm Tricorder XPRIZE, a 3.5-year global competition sponsored by the Qualcomm Foundation, in which teams develop a consumer-focused, mobile device much like the medical Tricorder of Star Trek® fame, moving it from science fiction to science reality.

“The challenge we are trying to solve for the Qualcomm Tricorder XPRIZE competition is an extremely difficult one, and one that requires enormous effort and collaboration,” said Walter de Brouwer, CEO of Scanadu. “What first attracted us to the competition was the promise of bringing together some of the brightest minds in the world to create a device that could give consumers access to their own health data, and we are thrilled to join forces with team zensor for the remainder of the competition to achieve this incredible feat together.”

“In the space of wearable medical technology, there is a convergence of traditional medical devices and consumer products, in more and more areas of functionality,” said Jim McLaughlin, CTO of Intelesens and Director at NIBEC - University of Ulster. “By working together and playing on each other’s strengths, team Scanadu/Intelesens expects to bring the reliability and accuracy of many areas of the medical device industry to the fast-paced world of the consumer.”

Scanadu and zensor were both announced as Qualcomm Tricorder XPRIZE finalist teams back in August 2014. To win this prize, teams must successfully create a device capable of diagnosing and interpreting a set of 15 medical conditions and capturing five vital health metrics. As part of the final round, teams will compete in both diagnostic experience evaluations and consumer testing at the University of California, San Diego’s Clinical and Translational Research Institute (CTRI), slated to begin in June 2015. The final judging and awards ceremony is scheduled to take place in early 2016.

About Scanadu

Based at NASA-Ames Research Center, Scanadu is using mobile and sensor technology to develop a portfolio of FDA approved, consumer friendly products that put the experience of an emergency room in the palm of your hand. Unveiled in November 2012, the company is working to ensure this is the last generation to know so little about our health. The product portfolio includes the Scanadu Scout vital sign monitor and Scanadu Urine, a urine analysis test. In July 2013, Scanadu became the most funded campaign on Indiegogo, enlisting supporters to be a part of the first usability study, followed by clinical studies for the company’s road to FDA approval. Scanadu was founded by Walter de Brouwer in 2011 and is a finalist for the Qualcomm Tricorder XPRIZE. For more information visit scanadu.com.

About Intelesens

Based in Belfast, Northern Ireland, Intelesens is a highly innovative medical technology company selling the world's first intelligent, non-invasive, wireless vital signs monitoring device for use in remote patient monitoring telehealth applications. It is a spin-out of the University of Ulster and is funded via private and venture capital investment. The Company has assembled a world-class team of employees that have established Intelesens at the forefront of exciting developments in the growing remote patient monitoring market. Intelesens, which was founded in 2001, is one of the finalists in the Qualcomm Xprize Competition.

Qualcomm is a trademark of Qualcomm Incorporated, registered in the United States and other countries.
STAR TREK, TRICORDER and related marks and logos are trademarks of CBS Studios Inc. Used under license.

Contact: The Hatch Agency scanadu@thehatchagency.com